News

De Novo Ventures of Palo Alto, California, led this round as well as SynergEyes’s series B round. Bio-Star Private Equity Fund joined series A and B investors: Alloy

The series A funding round will be used to continue the development and marketing of Linkage Biosciences’s line of diagnostic products. The molecular diagnostics technologies and innovations will

With the appointment of Mr Bowerman, Rick Pauls is stepping down as president and CEO of DiaMedica. Mr Pauls will continue to serve as chairman of the board

The ATS 3f aortic bioprosthesis is a next generation stentless pericardial aortic tissue valve. According to the company, the primary benefit of the ATS 3f aortic bioprosthesis is

Abbott has acquired co-exclusive clinical laboratory rights and exclusive in vitro diagnostic rights for commercialization of HDC’s tissue-based prostate cancer test as well as HDC’s urine-based prostate cancer

Under the licensing agreement, Scandinavian Gene Synthesis (SGS) will have rights to use their cGMP manufacturing capabilities to make and sell molecular diagnostic products incorporating the Nanogen molecular

The open-label, Simon two-stage study is designed to evaluate the safety and efficacy of the combination of bavituximab with the chemotherapy drugs carboplatin and paclitaxel in non-small cell

Mr Hen is a managing director at Warburg Pincus, a private equity firm. He focuses on investments in biotechnology and pharmaceuticals, including pharmaceutical outsourcing. Dr Zhao, one of

The compound proved to be least toxic and extremely effective in controlling the growth of SF295 human glioblastoma xenografts, the company said. According to PhytoMedical, in all cases